Advertisement

Topics

Aurinia Pharmaceuticals to Release First Quarter 2019 Financial Results on May 14, 2019

16:05 EDT 9 May 2019 | Businesswire

Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the “Company”) today announced that it will release its first quarter 2019 financial results on Tuesday, May 14, 2019, after the market closes. Aurinia’s management team will host a conference call to discuss the company’s financial results and to provide a general business update.

The conference call and webcast is scheduled for May 14, 2019 at 4:30pm ET. In order to participate in the conference call, please dial +1-877-407-9170 (Toll-free U.S. & Canada). An audio webcast can be accessed under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.

About Aurinia

Aurinia Pharmaceuticals Inc. is a late clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations impacted by serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and dry eye syndrome (DES). The company is headquartered in Victoria, British Columbia and focuses its development efforts globally. For further information, see our website at www.auriniapharma.com.

Investor Contact:
Glenn Schulman, PharmD, MPH
Corporate Communications
gschulman@auriniapharma.com
or
Media Contact:
Christopher Hippolyte
212-364-0458
Christopher.Hippolyte@inventivhealth.com

NEXT ARTICLE

More From BioPortfolio on "Aurinia Pharmaceuticals to Release First Quarter 2019 Financial Results on May 14, 2019"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...